Chinese General Practice ›› 2024, Vol. 27 ›› Issue (08): 948-954.DOI: 10.12114/j.issn.1007-9572.2023.0278
• Original Research • Previous Articles Next Articles
Received:
2023-04-15
Revised:
2023-07-12
Published:
2024-03-15
Online:
2023-12-19
Contact:
ZHANG Li
通讯作者:
张莉
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0278
组别 | 例数 | 年龄( | 性别[例(%)] | BMI ( | 主要诊断[例(%)] | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
男 | 女 | 呼吸系统疾病 | 循环系统疾病 | 中枢神经系统疾病 | 消化系统疾病 | 泌尿系统疾病 | 其他 | ||||
压力性损伤组 | 22 | 71.3±6.1 | 13(59.1) | 9(40.9) | 23.3±1.7 | 15(68.2) | 1(4.5) | 3(13.6) | 0 | 1(4.5) | 2(9.2) |
非压力性损伤组 | 137 | 60.5±9.3 | 79(57.7) | 58(42.3) | 23.1±1.8 | 98(71.5) | 0 | 29(21.2) | 0 | 2(1.5) | 8(5.8) |
检验统计量值 | 3.960a | 0.413b | 0.259a | 6.376b | |||||||
P值 | <0.001 | 0.563 | 0.796 | 0.173 | |||||||
组别 | 脓毒症[例(%)] | 糖尿病[例(%)] | 总住院时间[M(P25,P75),d] | ICU住院时间[M(P25,P75),d] | APACHEⅡ[M(P25,P75),分] | NRS 2002[M(P25,P75),分] | Braden评分[M(P25,P75),分] | 单次俯卧位时间( | |||
是 | 否 | 是 | 否 | ||||||||
压力性损伤组 | 8(36.4) | 14(63.6) | 17(77.3) | 5(22.7) | 21(20,23) | 16(15,17) | 16(11,19) | 4(4,5) | 11(10,12) | 13.6±2.9 | |
非压力性损伤组 | 10(7.3) | 127(92.7) | 38(27.7) | 99(72.3) | 20(18,23) | 13(11,15) | 14(11,18) | 4(4,5) | 11(10,12) | 6.6±2.0 | |
检验统计量值 | 2.419b | 10.550b | 1.364 | 3.274 | 0.635 | 0.810 | 0.468 | 11.025a | |||
P值 | 0.139 | 0.001 | 0.173 | 0.001 | 0.526 | 0.418 | 0.681 | <0.001 | |||
组别 | 总俯卧位时间( | 平均动脉压( | 镇静[例(%)] | RASS [M(P25,P75),分] | 机械通气方式[例(%)] | 营养方式[例(%)] | |||||
是 | 否 | 有创机械通气 | 无创机械通气 | 高流量鼻导管氧疗 | 肠内营养 | 肠外营养 | |||||
压力性损伤组 | 71.5±4.2 | 66.8±7.4 | 22(100.0) | 0 | -4(-3,-4) | 15(68.2) | 0 | 7(31.8) | 18(81.8) | 4(18.2) | |
非压力性损伤组 | 70.9±4.2 | 65.9±7.2 | 137(100.0) | 0 | -2(-3,-1) | 117(85.4) | 0 | 20(14.6) | 127(92.7) | 10(7.3) | |
检验统计量值 | 2.932a | 0.854a | -4.154 | 4.729b | 0.485b | ||||||
P值 | 0.004 | 0.429 | <0.001 | 0.030 | 0.486 | ||||||
组别 | 连续血液净化治疗[例(%)] | IABP治疗[例(%)] | 去甲肾上腺素剂量( | PaO2/FiO2 ( | 血乳酸( | 白蛋白( | 血红蛋白( | 静脉血葡萄糖( | |||
是 | 否 | 是 | 否 | ||||||||
压力性损伤组 | 12(54.5) | 10(45.5) | 3(13.6) | 19(86.4) | 0.7±0.1 | 139.5±23.9 | 2.4±0.9 | 33.7±3.0 | 99.0±14.8 | 12.1±1.6 | |
非压力性损伤组 | 25(18.3) | 112(81.7) | 5(3.6) | 132(96.4) | 0.3±0.1 | 212.4±21.4 | 2.8±0.9 | 33.7±2.7 | 104.5±14.4 | 13.3±2.6 | |
检验统计量值 | 2.921b | 10.831b | 14.161a | -11.248a | -1.699a | -1.238a | -1.269a | -1.647a | |||
P值 | 0.087 | 0.001 | <0.001 | <0.001 | 0.091 | 0.238 | 0.206 | 0.102 |
Table 1 Comparison of baseline data between the two groups
组别 | 例数 | 年龄( | 性别[例(%)] | BMI ( | 主要诊断[例(%)] | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
男 | 女 | 呼吸系统疾病 | 循环系统疾病 | 中枢神经系统疾病 | 消化系统疾病 | 泌尿系统疾病 | 其他 | ||||
压力性损伤组 | 22 | 71.3±6.1 | 13(59.1) | 9(40.9) | 23.3±1.7 | 15(68.2) | 1(4.5) | 3(13.6) | 0 | 1(4.5) | 2(9.2) |
非压力性损伤组 | 137 | 60.5±9.3 | 79(57.7) | 58(42.3) | 23.1±1.8 | 98(71.5) | 0 | 29(21.2) | 0 | 2(1.5) | 8(5.8) |
检验统计量值 | 3.960a | 0.413b | 0.259a | 6.376b | |||||||
P值 | <0.001 | 0.563 | 0.796 | 0.173 | |||||||
组别 | 脓毒症[例(%)] | 糖尿病[例(%)] | 总住院时间[M(P25,P75),d] | ICU住院时间[M(P25,P75),d] | APACHEⅡ[M(P25,P75),分] | NRS 2002[M(P25,P75),分] | Braden评分[M(P25,P75),分] | 单次俯卧位时间( | |||
是 | 否 | 是 | 否 | ||||||||
压力性损伤组 | 8(36.4) | 14(63.6) | 17(77.3) | 5(22.7) | 21(20,23) | 16(15,17) | 16(11,19) | 4(4,5) | 11(10,12) | 13.6±2.9 | |
非压力性损伤组 | 10(7.3) | 127(92.7) | 38(27.7) | 99(72.3) | 20(18,23) | 13(11,15) | 14(11,18) | 4(4,5) | 11(10,12) | 6.6±2.0 | |
检验统计量值 | 2.419b | 10.550b | 1.364 | 3.274 | 0.635 | 0.810 | 0.468 | 11.025a | |||
P值 | 0.139 | 0.001 | 0.173 | 0.001 | 0.526 | 0.418 | 0.681 | <0.001 | |||
组别 | 总俯卧位时间( | 平均动脉压( | 镇静[例(%)] | RASS [M(P25,P75),分] | 机械通气方式[例(%)] | 营养方式[例(%)] | |||||
是 | 否 | 有创机械通气 | 无创机械通气 | 高流量鼻导管氧疗 | 肠内营养 | 肠外营养 | |||||
压力性损伤组 | 71.5±4.2 | 66.8±7.4 | 22(100.0) | 0 | -4(-3,-4) | 15(68.2) | 0 | 7(31.8) | 18(81.8) | 4(18.2) | |
非压力性损伤组 | 70.9±4.2 | 65.9±7.2 | 137(100.0) | 0 | -2(-3,-1) | 117(85.4) | 0 | 20(14.6) | 127(92.7) | 10(7.3) | |
检验统计量值 | 2.932a | 0.854a | -4.154 | 4.729b | 0.485b | ||||||
P值 | 0.004 | 0.429 | <0.001 | 0.030 | 0.486 | ||||||
组别 | 连续血液净化治疗[例(%)] | IABP治疗[例(%)] | 去甲肾上腺素剂量( | PaO2/FiO2 ( | 血乳酸( | 白蛋白( | 血红蛋白( | 静脉血葡萄糖( | |||
是 | 否 | 是 | 否 | ||||||||
压力性损伤组 | 12(54.5) | 10(45.5) | 3(13.6) | 19(86.4) | 0.7±0.1 | 139.5±23.9 | 2.4±0.9 | 33.7±3.0 | 99.0±14.8 | 12.1±1.6 | |
非压力性损伤组 | 25(18.3) | 112(81.7) | 5(3.6) | 132(96.4) | 0.3±0.1 | 212.4±21.4 | 2.8±0.9 | 33.7±2.7 | 104.5±14.4 | 13.3±2.6 | |
检验统计量值 | 2.921b | 10.831b | 14.161a | -11.248a | -1.699a | -1.238a | -1.269a | -1.647a | |||
P值 | 0.087 | 0.001 | <0.001 | <0.001 | 0.091 | 0.238 | 0.206 | 0.102 |
变量 | 逐步Logistic回归模型 | 全变量Logistic回归模型 | Lasso-Logistic回归模型 | |||
---|---|---|---|---|---|---|
OR(95%CI) | P值 | OR(95%CI) | P值 | OR(95%CI) | P值 | |
年龄 | 39.041(8.772~73.754) | 0.004 | 26.882(2.246~92.809) | 0.005 | 38.256(4.728~109.551) | <0.001 |
糖尿病 | 7.256(1.873~28.104) | 0.025 | 1.770(1.050~62.266) | 0.046 | 1.094(1.035~11.357) | 0.004 |
ICU住院时间 | 2.610(1.194~35.184) | 0.006 | ||||
单次俯卧位时间 | 6.705(1.503~29.904) | 0.001 | 5.340(1.395~72.107) | 0.033 | 5.738(1.640~51.425) | 0.038 |
总俯卧位时间 | 1.152(0.721~1.840) | 0.119 | ||||
RASS | 0.238(0.054~1.046) | 0.096 | 1.179(1.047~1.679) | 0.031 | ||
有创机械通气 | 0.528(0.132~2.105) | 0.539 | ||||
高流量鼻导管氧疗 | 1.894(0.475~7.551) | 0.404 | ||||
血液净化治疗 | 2.480(0.142~43.242) | 0.765 | ||||
IABP | 4.086(0.084~98.346) | 0.621 | ||||
去甲肾上腺素 | 1.588(0.045~7.774) | 0.412 | ||||
PaO2/FiO2 | 0.997(0.603~1.081) | 0.968 | ||||
血乳酸 | 0.999(0.975~1.064) | 0.970 |
Table 2 Three Logistic regression models of prone position ventilation-related facial pressure injuries
变量 | 逐步Logistic回归模型 | 全变量Logistic回归模型 | Lasso-Logistic回归模型 | |||
---|---|---|---|---|---|---|
OR(95%CI) | P值 | OR(95%CI) | P值 | OR(95%CI) | P值 | |
年龄 | 39.041(8.772~73.754) | 0.004 | 26.882(2.246~92.809) | 0.005 | 38.256(4.728~109.551) | <0.001 |
糖尿病 | 7.256(1.873~28.104) | 0.025 | 1.770(1.050~62.266) | 0.046 | 1.094(1.035~11.357) | 0.004 |
ICU住院时间 | 2.610(1.194~35.184) | 0.006 | ||||
单次俯卧位时间 | 6.705(1.503~29.904) | 0.001 | 5.340(1.395~72.107) | 0.033 | 5.738(1.640~51.425) | 0.038 |
总俯卧位时间 | 1.152(0.721~1.840) | 0.119 | ||||
RASS | 0.238(0.054~1.046) | 0.096 | 1.179(1.047~1.679) | 0.031 | ||
有创机械通气 | 0.528(0.132~2.105) | 0.539 | ||||
高流量鼻导管氧疗 | 1.894(0.475~7.551) | 0.404 | ||||
血液净化治疗 | 2.480(0.142~43.242) | 0.765 | ||||
IABP | 4.086(0.084~98.346) | 0.621 | ||||
去甲肾上腺素 | 1.588(0.045~7.774) | 0.412 | ||||
PaO2/FiO2 | 0.997(0.603~1.081) | 0.968 | ||||
血乳酸 | 0.999(0.975~1.064) | 0.970 |
模型 | 区分度 | 校准度 | ||||
---|---|---|---|---|---|---|
AUC | 灵敏度 | 特异度 | AIC | BIC | R2 | |
逐步Logistic回归 | 0.771 | 0.959 | 0.583 | 46.564 | 64.327 | 0.681 |
全变量Logistic回归 | 0.736 | 0.973 | 0.500 | 51.876 | 67.220 | 0.692 |
Lasso-Logistic回归 | 0.855 | 0.959 | 0.750 | 44.634 | 55.745 | 0.721 |
Table 3 Predictive efficacy of different Logistic regression models
模型 | 区分度 | 校准度 | ||||
---|---|---|---|---|---|---|
AUC | 灵敏度 | 特异度 | AIC | BIC | R2 | |
逐步Logistic回归 | 0.771 | 0.959 | 0.583 | 46.564 | 64.327 | 0.681 |
全变量Logistic回归 | 0.736 | 0.973 | 0.500 | 51.876 | 67.220 | 0.692 |
Lasso-Logistic回归 | 0.855 | 0.959 | 0.750 | 44.634 | 55.745 | 0.721 |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
金珊珊,俞戈,谢晖,等. 基于LASSO回归的重症急性胰腺炎患者肺炎克雷伯杆菌感染风险预测模型建立[J]. 中华胰腺病杂志,2023,23(1):20-27. DOI:10.3760/cma.j.cn115667-20221010-00154.
|
[24] |
秦瑶,韩红娟,陈杜荣,等. 基于LASSO logistic回归模型的轻度认知障碍逆转预测模型[J]. 中国卫生统计,2022,39(5):653-658. DOI:10.3969/j.issn.1002-3674.2022.05.003.
|
[25] |
黄娅,李运明,雷丽. Lasso Logistic回归模型识别脂肪肝风险因素效果研究[J]. 甘肃科学学报,2021,33(4):45-51. DOI:10.16468/j.cnki.issn1004-0366.2021.04.008.
|
[1] | XU Baichuan, WANG Yan, ZHANG Peng, LI Yiting, LIU Feilai, XIE Yang. Research and Analysis of Screening Tools for Chronic Obstructive Pulmonary Disease Comorbidity Lung Cancer [J]. Chinese General Practice, 2025, 28(30): 3847-3852. |
[2] | SHAO Xiaoying, SHAO Jie, ZHU Yan, SHAO Jinling, SHANG Ling, WU Zhenlian, ZHAO Yu, ZHANG Jiacai. Analysis of the Current Status of Iron Deficiency and Factors Affecting Iron Deficiency Anemia among Children Aged 6-36 Months in Guizhou Province [J]. Chinese General Practice, 2025, 28(27): 3368-3374. |
[3] | ZHOU Qian, WU Xiaomin, WANG Baohua, YAN Ruohan, YU Miao, WU Jing. Study on Nomogram Prediction Model for Risk of Gastric Cancer [J]. Chinese General Practice, 2025, 28(23): 2870-2877. |
[4] | GUO Shengteng, ZHANG Fenfen, WAN Di, YU Dongmei, WANG Qinghua. Risk Factors for Severe Acute Pancreatitis Complicated with Acute Lung Injury: a Meta-analysis [J]. Chinese General Practice, 2025, 28(20): 2546-2554. |
[5] | WANG Xiaoyu, FENG Zhenzhen, WANG Jun, GUO Xiaochuan, LI Jiansheng. Risk Factors for Acute Kidney Injury in Acute Respiratory Distress Syndrome: a Systematic Review [J]. Chinese General Practice, 2025, 28(12): 1527-1537. |
[6] | SUN Lin, SHI Yiwei, HOU Xiaomin, GUO Yunting, ZHAO Xu, DONG Lin, NIE Jisheng, QIN Xiaojiang. Relationship between Serum Sodium Levels and Length of Hospital Stay in Patients with Pulmonary Hypertension associated with Left Heart Disease [J]. Chinese General Practice, 2025, 28(09): 1065-1071. |
[7] | LIAO Xingyu, TIAN Siyu, CHEN Min. The Disease Burden, Risk Factors and Predictive Analysis of Early-onset Colorectal Cancer of Different Genders between China and the World from 1990 to 2021 [J]. Chinese General Practice, 2025, 28(08): 1004-1011. |
[8] | ZOU Songyan, ZHANG Riyi, LI Xiaodong, MU Yinyu. Analysis of Clinical Characteristics and Risk Factors of Systemic Sclerosis Combined with Sjögren's Syndrome [J]. Chinese General Practice, 2025, 28(06): 737-741. |
[9] | WANG Yuan, XIAO Fei, ZHANG Yuxin, ZHOU Enhui, ZHONG Jianqin, HU Yuxin, HONG Feng. Relationship between Ethnic Minority Speciality Diets and Cardiovascular Disease: Based on the Cohort Study of Natural Populations Living in Ethnic Minority Aggregation Areas in the Southwest Region [J]. Chinese General Practice, 2025, 28(06): 688-696. |
[10] | SHI Xiaotian, WANG Shan, YANG Huayu, YANG Yifan, LI Xu, DOU Guoze, MA Qing. A Predictive Nomogram for the Risk of Frailty/Pre-frailty on Inflammatory Biomarkers in the Elderly [J]. Chinese General Practice, 2025, 28(05): 587-593. |
[11] | KONG Linghong, XIE Xiaoxin, FU Yanhua, GAN Lin, YANG Xiaoyan, MA Shujing, LONG Hai. Pre-treatment and Acquired Antiretroviral Drug Resistance among People Living with HIV in Southwest China [J]. Chinese General Practice, 2025, 28(02): 242-249. |
[12] | LIU Mingbo, HE Xinye, YANG Xiaohong, WANG Zengwu. Interpretation of Report on Cardiovascular Health and Diseases in China 2023 [J]. Chinese General Practice, 2025, 28(01): 20-38. |
[13] | TAO Jintao, WU Shouling, ZHAO Xiaohong. Prevalence and Risk Factors of Atrioventricular Block in the Population: a Study Based on the Kailuan Cohort [J]. Chinese General Practice, 2024, 27(36): 4534-4539. |
[14] | GU Shanye, ZHOU Ziyi, CAI Yefeng. Study on Risk Prediction of Non-dementia Vascular Cognitive Impairment in Glycolipid Metabolic Diseases [J]. Chinese General Practice, 2024, 27(35): 4412-4416. |
[15] | ZHANG Bingqing, HU Xinyun, OUYANG Yuqin, XIANG Xinyue, TANG Wenjuan, FENG Wenhuan. Study on Nomogram Prediction Model for Risk Factors of Muscle Mass Loss in Non-obese Patients with Type 2 Diabetes [J]. Chinese General Practice, 2024, 27(33): 4139-4146. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||